Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.
Storti, P
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo. [electronic resource] - Leukemia 12 2016 - 2351-2363 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5551
10.1038/leu.2016.137 doi
Animals
Cell Hypoxia
Cell Line, Tumor
Cell Proliferation
Galectin 1--antagonists & inhibitors
Humans
Mice
Multiple Myeloma--blood supply
Neovascularization, Pathologic--drug therapy
RNA, Small Interfering--pharmacology
Transfection
Tumor Burden--drug effects
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo. [electronic resource] - Leukemia 12 2016 - 2351-2363 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5551
10.1038/leu.2016.137 doi
Animals
Cell Hypoxia
Cell Line, Tumor
Cell Proliferation
Galectin 1--antagonists & inhibitors
Humans
Mice
Multiple Myeloma--blood supply
Neovascularization, Pathologic--drug therapy
RNA, Small Interfering--pharmacology
Transfection
Tumor Burden--drug effects